Literature DB >> 26492208

Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis.

Claudia Guevara1, Chengxian Zhang1, Jennifer A Gaddy2,3, Junaid Iqbal1, Julio Guerra1, David P Greenberg4,5, Michael D Decker5,6, Nicholas Carbonetti7, Timothy D Starner8, Paul B McCray8, Frits R Mooi9, Oscar G Gómez-Duarte1.   

Abstract

BACKGROUND: Bordetella pertussis colonizes the human respiratory mucosa. Most studies on B. pertussis adherence have relied on cultured mammalian cells that lack key features present in differentiated human airway cells or on animal models that are not natural hosts of B. pertussis. The objectives of this work were to evaluate B. pertussis infection in highly differentiated human airway cells in vitro and to show the role of B. pertussis fimbriae in cell adherence.
METHODS: Primary human airway epithelial (PHAE) cells from human bronchi and a human bronchial epithelial (HBE) cell line were grown in vitro under air-liquid interface conditions.
RESULTS: PHAE and HBE cells infected with B. pertussis wild-type strain revealed bacterial adherence to the apical surface of cells, bacteria-induced cytoskeleton changes, and cell detachment. Mutations in the major fimbrial subunits Fim2/3 or in the minor fimbrial adhesin subunit FimD affected B. pertussis adherence to predominantly HBE cells. This cell model recapitulates the morphologic features of the human airway infected by B. pertussis and confirms the role of fimbriae in B. pertussis adherence. Furthermore, HBE cells show that fimbrial subunits, and specifically FimD adhesin, are critical in B. pertussis adherence to airway cells.
CONCLUSIONS: The relevance of this model to study host-parasite interaction in pertussis lies in the striking physiologic and morphologic similarity between the PHAE and HBE cells and the human airway ciliated and goblet cells in vivo. These cells can proliferate in vitro, differentiate, and express the same genetic profile as human respiratory cells in vivo.

Entities:  

Keywords:  Bordetella pertussis; adherence; fimbriae major subunit Fim2 or Fim3; minor subunit FimD

Mesh:

Substances:

Year:  2015        PMID: 26492208      PMCID: PMC5278880          DOI: 10.3109/23744235.2015.1100323

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  44 in total

Review 1.  Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.

Authors:  J R Kerr; R C Matthews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-02       Impact factor: 3.267

Review 2.  Bordetella pertussis, molecular pathogenesis under multiple aspects.

Authors:  C Locht; R Antoine; F Jacob-Dubuisson
Journal:  Curr Opin Microbiol       Date:  2001-02       Impact factor: 7.934

3.  Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae.

Authors:  F R Mooi; W H Jansen; H Brunings; H Gielen; H G van der Heide; H C Walvoort; P A Guinee
Journal:  Microb Pathog       Date:  1992-02       Impact factor: 3.738

4.  Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.

Authors:  Kaatje Smits; Gaelle Pottier; Julie Smet; Violette Dirix; Françoise Vermeulen; Iris De Schutter; Maria Carollo; Camille Locht; Clara Maria Ausiello; Françoise Mascart
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

Review 5.  Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.

Authors:  Drusilla L Burns; Bruce D Meade; Nancy E Messionnier
Journal:  J Infect Dis       Date:  2014-04-01       Impact factor: 5.226

6.  Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD.

Authors:  W L Hazenbos; C A Geuijen; B M van den Berg; F R Mooi; R van Furth
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

7.  Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.

Authors:  Maria-Rosa Sala-Farré; César Arias-Varela; Assumpta Recasens-Recasens; Maria Simó-Sanahuja; Carmen Muñoz-Almagro; Josefa Pérez-Jové
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-11-09       Impact factor: 1.731

8.  Isolation of a putative fimbrial adhesin from Bordetella pertussis and the identification of its gene.

Authors:  R J Willems; C Geuijen; H G van der Heide; M Matheson; A Robinson; L F Versluis; R Ebberink; J Theelen; F R Mooi
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

9.  Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40.

Authors:  D C Gruenert; C B Basbaum; M J Welsh; M Li; W E Finkbeiner; J A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.

Authors:  Hans Hallander; Abdolreza Advani; Frances Alexander; Lennart Gustafsson; Margaretha Ljungman; Catherine Pratt; Ian Hall; Andrew R Gorringe
Journal:  Clin Vaccine Immunol       Date:  2013-12-04
View more
  9 in total

Review 1.  Bordetella pertussis: new concepts in pathogenesis and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

Review 2.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

3.  Bordetella pertussis Adenylate Cyclase Toxin Disrupts Functional Integrity of Bronchial Epithelial Layers.

Authors:  Shakir Hasan; Nikhil Nitin Kulkarni; Arni Asbjarnarson; Irena Linhartova; Radim Osicka; Peter Sebo; Gudmundur H Gudmundsson
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

4.  Histopathology of Bordetella pertussis in the Baboon Model.

Authors:  Lindsey I Zimmerman; James F Papin; Jason Warfel; Roman F Wolf; Stanley D Kosanke; Tod J Merkel
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

5.  Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients.

Authors:  Elise S Hovingh; Betsy Kuipers; Axel A Bonačić Marinović; Hendrik Jan Hamstra; Danielle Hijdra; Lapo Mughini Gras; Inonge van Twillert; Ilse Jongerius; Cecile A C M van Els; Elena Pinelli
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

6.  Susceptibility of primary human airway epithelial cells to Bordetella pertussis adenylate cyclase toxin in two- and three-dimensional culture conditions.

Authors:  Maria Bianchi; Rinu Sivarajan; Thorsten Walles; Stephan Hackenberg; Maria Steinke
Journal:  Innate Immun       Date:  2020-12-14       Impact factor: 2.680

7.  Susceptibility of Human Airway Tissue Models Derived From Different Anatomical Sites to Bordetella pertussis and Its Virulence Factor Adenylate Cyclase Toxin.

Authors:  Rinu Sivarajan; David Komla Kessie; Heike Oberwinkler; Niklas Pallmann; Thorsten Walles; Agmal Scherzad; Stephan Hackenberg; Maria Steinke
Journal:  Front Cell Infect Microbiol       Date:  2021-12-23       Impact factor: 5.293

8.  Bordetella pertussis induces IFN-γ production by NK cells resulting in chemo-attraction by respiratory epithelial cells.

Authors:  Gerco den Hartog; Marcel A Schijf; Guy A M Berbers; Fiona R M van der Klis; Anne-Marie Buisman
Journal:  J Infect Dis       Date:  2020-03-27       Impact factor: 5.226

Review 9.  Invited review: human air-liquid-interface organotypic airway tissue models derived from primary tracheobronchial epithelial cells-overview and perspectives.

Authors:  Xuefei Cao; Jayme P Coyle; Rui Xiong; Yiying Wang; Robert H Heflich; Baiping Ren; William M Gwinn; Patrick Hayden; Liying Rojanasakul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-11-11       Impact factor: 2.723

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.